FeedVax
PrivateLast Round
Seed
Sep 15, 2022
Total Funding Raised
$311,000
Company Overview
FeedVax is a biotechnology company that develops an oral in-feed vaccine platform designed to deliver health treatments to farmed animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FeedVax Comps
Public and private peers based on sector, stage, and business model.
FeedVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 15, 2022 | ||||
| Accelerator | Dec 30, 2021 | ||||
| Accelerator | Aug 26, 2019 |
FeedVax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRIDX | Pre Seed |
| Ponderosa Ventures | Seed |
| The Yield Lab Asia Pacific | Accelerator |
| CI Ventures | Seed |
| Hatch Blue | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2022
Seed round led by CI Ventures.
- Dec 30, 2021
The Yield Lab Asia Pacific participated in the round.
FeedVax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FeedVax's valuation, stock price, and market status.
